Controlled Surface Modification with Poly(ethylene)glycol Enhances Diffusion of PLGA Nanoparticles in Human Cervical Mucus

被引:211
作者
Cu, Yen [1 ]
Saltzman, W. Mark [1 ]
机构
[1] Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA
基金
美国国家卫生研究院;
关键词
Mucosal transport; diffusion model; polymer nanoparticles; surface modification; stealth; drug delivery; mucin; PEG CHAIN-LENGTH; GENE-TRANSFER; PARTICLES; DRUG; PLA; BIODISTRIBUTION; MACROMOLECULES; NANOCAPSULES; NANOSPHERES; TRANSPORT;
D O I
10.1021/mp8001254
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Drug delivery to mucosal epithelia is severely limited by the mucus gel, which is a physical diffusion barrier as well as an enzymatic barrier in some sites. Loading of drug into polymer particles can protect drugs from degradation and enhance their stability. To improve efficacy of nanoparticulate drug carriers, it has been speculated that polymers such as poly(ethylene)glycol (PEG) incorporated on the particle surface will enhance transport in mucus. In the present study, we demonstrate the direct influence of PEG on surface properties of poly(lactic-co-glycolic)acid (PLGA) nanoparticles (d = 170 +/- 57 nm). PEG of various molecular weights (MW = 2, 5, 10 kDa) were incorporated at a range of densities from 5-100% on the particle surface. Our results indicate PEG addition improves dispersion, neutralize charge, and enhance particle diffusion in cervical mucus in a manner strongly dependent on polymer MW and density. Diffusion of PEGylated particles was 3-10x higher than that of unmodified PLGA particles. These findings improve the understanding of, and confirm a possible direction for, the rational design of effective carriers fog mucosal drug/vaccine delivery.
引用
收藏
页码:173 / 181
页数:9
相关论文
共 27 条
[21]   ANTIBODY DIFFUSION IN HUMAN CERVICAL-MUCUS [J].
SALTZMAN, WM ;
RADOMSKY, ML ;
WHALEY, KJ ;
CONE, RA .
BIOPHYSICAL JOURNAL, 1994, 66 (02) :508-515
[22]   SURFACE MODIFICATION OF POLY(LACTIDE-CO-GLYCOLIDE) NANOSPHERES BY BIODEGRADABLE POLY(LACTIDE)-POLY(ETHYLENE GLYCOL) COPOLYMERS [J].
STOLNIK, S ;
DUNN, SE ;
GARNETT, MC ;
DAVIES, MC ;
COOMBES, AGA ;
TAYLOR, DC ;
IRVING, MP ;
PURKISS, SC ;
TADROS, TF ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (12) :1800-1808
[23]  
Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016
[24]   The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration [J].
Tobío, M ;
Sánchez, A ;
Vila, A ;
Soriano, I ;
Evora, C ;
Vila-Jato, JL ;
Alonso, MJ .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2000, 18 (3-4) :315-323
[25]   Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density [J].
Vila, A ;
Gill, H ;
McCallion, O ;
Alonso, MJ .
JOURNAL OF CONTROLLED RELEASE, 2004, 98 (02) :231-244
[26]   Efficient gene transfer to airway epithelium using recombinant Sendai virus [J].
Yonemitsu, Y ;
Kitson, C ;
Ferrari, S ;
Farley, R ;
Griesenbach, U ;
Judd, D ;
Steel, R ;
Scheid, P ;
Zhu, J ;
Jeffery, PK ;
Kato, A ;
Hasan, MK ;
Nagai, Y ;
Masaki, I ;
Fukumura, M ;
Hasegawa, M ;
Geddes, DM ;
Alton, EWFW .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :970-973
[27]   Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicin [J].
Yu, J. J. ;
Lee, H. A. ;
Kim, J. H. ;
Kong, W. H. ;
Kim, Y. ;
Cui, Z. Y. ;
Park, K. G. ;
Kim, W. S. ;
Lee, H. G. ;
Seo, S. W. .
JOURNAL OF DRUG TARGETING, 2007, 15 (04) :279-284